SCHEMBL4851981

SCHEMBL4851981

COc1ccc(C(=O)C=Cc2cc(-c3cc(C)cc(C)c3)ccc2OCCN(C)C)c(OC)c1OC

nearest known ligand 0.46

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CHRNA7 P36544 1/20 0.46
TUBB1 Q9H4B7 3/20 0.46
TNFRSF1A P19438 4/20 0.46
ALOX5 P09917 1/20 0.43
MCL1 Q07820 3/20 0.43
CYP1A1 P04798 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP1B1 Q16678 1/20 0.41
PDE4A P27815 1/20 0.41
PDE4B Q07343 1/20 0.41
PDE4C Q08493 1/20 0.41
PDE4D Q08499 1/20 0.41
ABCG2 Q9UNQ0 1/20 0.41
CYP3A4 P08684 1/20 0.41
ALDH1A1 P00352 1/20 0.40
BCHE P06276 1/20 0.39
ACHE P22303 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4854640 0.90 CHRNA7 (0.51) CHRNA7TUBB1ALOX5CYP1A1CYP1A2
SCHEMBL4851978 0.90 CHRNA7 (0.51) CHRNA7TUBB1ALOX5CYP1A1CYP1A2
SCHEMBL4845551 0.89 MCHR1 (0.49) CHRNA7TUBB1TNFRSF1AALOX5MCL1
SCHEMBL4852831 0.89 TUBB1 (0.50) CHRNA7TUBB1TNFRSF1AALOX5MCL1
SCHEMBL4850165 0.86 TNFRSF1A (0.48) CHRNA7TUBB1TNFRSF1AALOX5MCL1
SCHEMBL4845636 0.86 TNFRSF1A (0.49) CHRNA7TUBB1TNFRSF1AALOX5MCL1
SCHEMBL4846217 0.85 CHRNA7 (0.58) CHRNA7TUBB1TNFRSF1AALOX5MCL1
SCHEMBL4852271 0.84 PDE4A (0.46) TNFRSF1APDE4APDE4BPDE4CPDE4D
SCHEMBL4846635 0.84 LMNA (0.48) TNFRSF1APDE4APDE4BPDE4CPDE4D
SCHEMBL4848333 0.84 PDE4A (0.46) TNFRSF1APDE4APDE4BPDE4CPDE4D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050227990-A1 Aminoalkoxy-functional chalcones LICA PHARMACEUTICALS A/S (DK) 2005-10-13 US claimed
US-7423181-B2 in particular against bacterial and parasitic infections, fungi, and helminths; improved metabolic and physiochemical properties, bioavailability, solubility; 3-[4-(2-Dimethylamino-ethoxy)-2'-trifluoromethyl-biphenyl-3-yl]-1-(2-dimethylaminomethyl-phenyl)-propenone LICA PHARMACEUTICALS A/S (DK) 2008-09-09 US disclosed
US-20050227990-A1 Aminoalkoxy-functional chalcones LICA PHARMACEUTICALS A/S (DK) 2005-10-13 US disclosed